Research team finds an antibody that recognizes DNA shape and responds to antibiotic-induced structural changes
DNA aptamers are attracting attention as alternatives to antibodies in biosensing and diagnostics. Yet little is known about whether antibodies themselves can recognize the folded structures of DNA aptamers. Researchers at Saitama University have now identified a VHH antibody that preferentially binds an oxytetracycline-associated DNA aptamer.
Researchers at Saitama University have discovered a VHH antibody that specifically binds a DNA aptamer shaped by the presence of oxytetracycline (OTC), an antibiotic. DNA aptamers are short, single-stranded DNA molecules that fold into unique structures and bind to specific targets, such as proteins or small chemicals. While DNA aptamers have gained attention as alternatives to antibodies in biosensing and diagnostics, little is known about whether antibodies can recognize the folded structures of DNA aptamers.
The Saitama University research team aimed to determine if small, single-domain antibodies (VHH antibodies) could recognize the structural characteristics of DNA aptamers. By using cDNA display technology, surface plasmon resonance, and AlphaFold3 predictions, they identified a promising VHH antibody, VHH6, whose binding behavior is influenced by the DNA aptamer's structure and the presence of OTC.
This study, published in the journal Antibodies, demonstrates that antibodies can recognize the three-dimensional features of DNA aptamers, opening new possibilities for understanding and engineering protein-nucleic acid interactions. Potential applications include developing molecular detection systems that combine the target-binding ability of DNA aptamers with the recognition capabilities of VHH antibodies, such as creating a "sandwich-like" detection system for small molecules.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.